Heart Failure Clinics

Papers
(The median citation count of Heart Failure Clinics is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Heart Failure with Preserved Ejection Fraction54
Valvular Regurgitation in Adults with Congenital Heart Disease and Heart Failure33
Unusual Forms of Pulmonary Hypertension27
Tafamidis in the Treatment of ATTR-related Cardiomyopathy26
Treatment of Advanced Heart Failure—Focus on Transplantation and Durable Mechanical Circulatory Support26
Contents25
Exercise Intolerance in Heart Failure with Preserved Ejection Fraction25
Changing Landscape of Heart Failure Imaging22
Diagnosis and Management of Cardiovascular Involvement in Friedreich Ataxia21
Forthcoming Issues21
Therapy-Related Clonal Hematopoiesis20
Understanding Myocardial Metabolism in the Context of Cardio-Oncology20
When all Else Fails, Try This19
Viral Myocarditis and Dilated Cardiomyopathy as a Consequence—Changing Insights from Advanced Imaging19
Mitral Regurgitation18
Rare Cardiovascular Diseases: From Genetics to Personalized Medicine18
Preload Reduction Therapies in Heart Failure18
Genetics of High-Altitude Pulmonary Edema18
Heart Failure in Adults with Congenital Heart Disease: The Time to Act is Now17
Contributors16
Arrhythmias in Adult Congenital Heart Disease Heart Failure16
Contributors16
Contributors15
Hypertension and Heart Failure with Preserved Ejection Fraction15
The Role of Echocardiography for the Clinical Diagnosis, Risk Stratification, and Management of Cardiac Amyloidosis14
Specific Therapy in Transthyretin Amyloid Cardiomyopathy13
Heart Failure Clinics13
Copyright13
Atrial Fibrillation and Heart Failure with Preserved Ejection Fraction12
Myocardial Dysfunction in Patients with Cancer12
Medical Therapy and Monitoring in Adult Congenital Heart Disease Heart Failure12
Emerging Roles for Artificial Intelligence in Heart Failure Imaging12
Coronary Angiography in the Evaluation of Systolic Heart Failure11
Contributors10
Advanced Heart Failure in a Special Population10
Special Considerations for Mechanical Circulatory Support or Device Therapy in Adult Congenital Heart Disease Heart Failure10
Interventional Management of Atrial Fibrillation in the Chronic Heart Failure Population10
Arrythmia-Mediated Valvular Heart Disease10
Guide to Temporary Mechanical Support in Cardiogenic Shock10
Cardiac Amyloidosis9
Pulmonary Arterial Hypertension in Connective Tissue Diseases Beyond Systemic Sclerosis9
Contents9
Cardiac Contractility Modulation9
SGLT2 Inhibitors in Heart Failure9
Contributors9
Evaluation and Management of Cardiac Sarcoidosis with Advanced Imaging9
Application of 3D Printing Technology in Heart Failure9
Noncoding RNAs in Pulmonary Arterial Hypertension9
The Role of Multimodality Imaging in the Evaluation of Heart Failure and Surgical Transplant Planning of Patients with Adult Congenital Heart Disease9
Copyright8
Inotropes in Patients with Advanced Heart Failure8
Preface8
SGLT2 Inhibitors in Type 2 Diabetes Mellitus7
Exercise Training and Rehabilitation in Cardiac Amyloidosis (ERICA) Study7
Disease-modifier Drugs in Patients with Advanced Heart Failure7
Glucose-Lowering and Metabolic Effects of SGLT2 Inhibitors7
Contents7
The Direct and Indirect Effects of COVID-19 on Acute Coronary Syndromes7
Echocardiography in Advanced Heart Failure for Diagnosis, Management, and Prognosis7
Sleep Disorder and Heart Failure with Preserved Ejection Fraction6
Advanced Heart Failure in Special Population6
Contents6
Aortic Valvular Stenosis and Heart Failure6
Adults with Congenital Heart Disease and Transplant6
Advanced Heart Failure: From Pathophysiology to Clinical Management6
Evaluation and Management of Arrhythmias in Ischemic Cardiomyopathy6
Vision Statement and Call to Action for Adult Congenital Heart Disease Heart Failure6
Phenomapping Heart Failure with Preserved Ejection Fraction Using Machine Learning Cluster Analysis6
Copyright6
Contents5
Remote Monitoring Devices and Heart Failure5
Exercise Testing in Pulmonary Hypertension and Heart Failure5
Clinical Use of Biomarkers in Cardiac Amyloidosis5
SGLT2 Inhibitors and Peripheral Vascular Events5
Clinical Practice Guidelines in Cardio-Oncology5
Novel Non-pharmacological Approaches to Heart Failure4
Pathophysiology of Cardiac Amyloidosis4
Coronary Microvascular Dysfunction4
Pulmonary Hypertension in Adult Congenital Heart Disease–Related Heart Failure4
Contributors4
The Risk of Sudden Unexpected Cardiac Death in Children4
Advances in the Therapy of Light Chain Cardiac Amyloidosis4
Clinical Phenogroups in Heart Failure with Preserved Ejection Fraction4
Sequencing Quadruple Therapy for Heart Failure with Reduced Ejection Fraction: Does It Really Matter?4
Contributors4
Contributors4
Mechanical Complication of Acute Myocardial Infarction Secondary to COVID-19 Disease4
Forthcoming Issues4
Latest Updates in Heart Failure Imaging4
Imaging in Hypertrophic Cardiomyopathy: Beyond Risk Stratification3
Novel Approaches to Sleep Apnea in Heart Failure3
Copyright3
Contents3
Sodium Glucose Cotransporter 2 Inhibitors, Amputation Risk, and Fracture Risk3
Copyright3
Changing Landscape of Heart Failure Imaging3
Forthcoming Issues3
Adult Congenital Heart Disease3
Epidemiology, Pathogenesis, and Clinical Course of Takotsubo Syndrome3
A Review of ST-Elevation Myocardial Infarction in Patients with COVID-192
Heart Failure Staging and Indications for Advanced Therapies in Adults with Congenital Heart Disease2
Renal Dysfunction and Heart Failure with Preserved Ejection Fraction2
Clinical and Molecular Aspects of Naxos Disease2
Secondary Mitral Regurgitation and Transcatheter Mitral Valve Therapies2
Obesity and Heart Failure with Preserved Ejection Fraction2
Contributors2
Review of Immunologic Manifestations of COVID-19 Infection and Vaccination2
Contents2
Forthcoming Issues2
Contents2
Use of Oral Anticoagulant Drugs in Patients with Pulmonary Hypertension2
Contributors2
Percutaneous Coronary Intervention for Heart Failure due to Coronary Artery Disease2
Mechanical Circulatory Support in COVID-192
Translational Cardio-Oncology Research to Promote Better Outcomes for One and All2
Copyright2
The Heart Muscle and Valve Involvement in Marfan Syndrome, Loeys-Dietz Syndromes, and Collagenopathies2
Using Artificial Intelligence to Better Predict and Develop Biomarkers2
Monitoring for Valve Decrepitude: Surveillance Echo for All at Age 60…?2
Challenges in Pulmonary Hypertension2
Surgical Revascularization Decisions in Ischemia and Heart Failure1
Multimodality Imaging in Aortic Stenosis1
Contributors1
Copyright1
Left Ventricular Assist Device1
Congestion in Patients with Advanced Heart Failure1
Forthcoming Issues1
Extracardiac Prothrombotic Effects of COVID-191
Challenges in Pulmonary Hypertension1
Management of COVID-19 in Patients with Pulmonary Arterial Hypertension1
Cardiopulmonary Exercise Testing in Research1
Valvular Heart Failure due to Tricuspid Regurgitation1
SGLT2 Inhibitors in Heart Failure with Reduced Ejection Fraction1
Obesity in Heart Failure with Reduced Ejection Fraction1
Cardiac PET Imaging for Coronary Artery Disease and Heart Failure1
Copyright1
Translational Research in Cardio-Oncology1
Use and Prognostic Implications of Cardiac Troponin in COVID-191
Cardiac Resynchronization Therapy and Cardiac Contractility Modulation in Patients with Advanced Heart Failure1
Pathophysiology of Heart Failure with Preserved Ejection Fraction1
Contents1
Contributors1
SGLT2 Inhibitors and Heart Failure with Preserved Ejection Fraction1
How to Start an Invasive Cardiopulmonary Exercise Testing Program1
Epidemiology and Definition of Heart Failure in Adult Congenital Heart Disease0
Training and Career Development in Cardio-Oncology Translational and Implementation Science0
New Frontiers in the Treatment of Homozygous Familial Hypercholesterolemia0
Contributors0
Cardioprotection of High-Risk Individuals0
Amyloid Cardiomyopathies: Clinical, Diagnostic and Therapeutic Aspects0
Machine Learning in Cardiovascular Imaging0
Arrhythmogenic Cardiomyopathy0
Copyright0
Tricuspid Regurgitation and Right Heart Failure0
Contents0
Interatrial Shunt Devices0
Cardiovascular Health Care Implications of the COVID-19 pandemic0
Palliative Care in Adult Congenital Heart Disease–Associated Advanced Heart Disease0
Evaluation of Coronary Artery Disease and Ischemia by Echocardiography0
Heart Failure Preserved Ejection Fraction in Women0
Artificial Intelligence and Mechanical Circulatory Support0
Cardiac Implantable Electronic Devices in Ischemic Cardiomyopathy0
Primary Mitral Regurgitation and Heart Failure0
Genetics in Congenital Heart Diseases0
Listing Criteria for Heart Transplant0
Contents0
Forthcoming Issues0
The Arrhythmic Phenotype in Cardiomyopathy0
Copyright0
Immune Dysregulation in Ischemic Heart Disease Among Individuals with Human Immunodeficiency Virus0
T-cell Immunotherapy and Cardiovascular Disease0
Contents0
Advanced Heart Failure in Special Population—Pediatric Age0
Forthcoming Issues0
Contents0
Copyright0
Intracellular Signaling Pathways Mediating Tyrosine Kinase Inhibitor Cardiotoxicity0
Contributors0
Modeling Susceptibility to Cardiotoxicity in Cancer Therapy Using Human iPSC-Derived Cardiac Cells and Systems Biology0
Current Status of Pharmacologic and Nonpharmacologic Therapy in Heart Failure with Preserved Ejection Fraction0
Hypertrophic Cardiomyopathy in RASopathies0
Copyright0
Comprehensive Assessment of Heart Failure with Preserved Ejection Fraction Using Cardiac MRI0
The Influence of Genotype on the Phenotype, Clinical Course, and Risk of Adverse Events in Children with Hypertrophic Cardiomyopathy0
Interventional Approaches to Augment Pharmacotherapy in Heart Failure0
Valvular Heart Disease and Heart Failure0
Exercise Training in Patients with Chronic Thromboembolic Pulmonary Hypertension and Pulmonary Arterial Hypertension0
Digital Health0
The Economic Burden of Heart Failure with Reduced Ejection Fraction0
Arrhythmic Stratification of Cardiac Amyloidosis0
Cardiopulmonary Exercise Testing in Pulmonary Hypertension0
Forthcoming Issues0
Oxygen Therapy in Pulmonary Vascular Disease0
Genotype-Phenotype Correlations in ATTR Amyloidosis0
How to Treat Right Heart Failure. Tips for Clinicians in Everyday Practice0
Contributors0
Standard Therapy in Cardiac Amyloidosis0
Failing with Cyanosis-Heart Failure in End-Stage Unrepaired or Partially Palliated Congenital Heart Disease0
The Uncertain Benefit from Implantable Cardioverter-Defibrillators in Nonischemic Cardiomyopathy0
Cardiac Amyloidosis0
Forthcoming Issues0
Forthcoming Issues0
Surgical Considerations in Adult Congenital Heart Disease Heart Failure0
Mildly Elevated Pulmonary Hypertension0
Coronary Artery Disease and Heart Failure—Continued Significant Morbidity and Mortality Highlights Need for Comprehensive Evaluation to Individualize Patient Management0
Cardiovascular Effects of COVID-190
Secondary Mitral Regurgitation and Heart Failure0
Digital Transformation in Medicine to Enhance Quality of Life, Longevity, and Health Equity0
Pregnancy and Pulmonary Hypertension0
Contents0
Heart Failure with Reduced Ejection Fraction0
Contributors0
Forthcoming Issues0
Clinical Manifestations of 22q11.2 Deletion Syndrome0
Pathophysiology of Advanced Heart Failure0
Utilizing Artificial Intelligence to Enhance Health Equity Among Patients with Heart Failure0
SGLT-2 Inhibitors0
Contents0
The Role of New Imaging Technologies in the Diagnosis of Cardiac Amyloidosis0
Sodium-Glucose Cotransporter-2 Inhibitors: Impact on Atherosclerosis and Atherosclerotic Cardiovascular Disease Events0
The Role of Scintigraphy with Bone Radiotracers in Cardiac Amyloidosis0
Impact of Coronavirus Disease 2019 Pandemic on Cardiac Arrest and Emergency Care0
Contents0
Racial, Ethnic, and Gender Disparities in Valvular Heart Failure Management0
Left Ventricular Assist Device and the Current State of the Art: HeartMate 3 at 5 Years0
Exercise Testing in Elite Athletes0
PET Imaging for Cardiomyopathy Challenges Simplistic Notions of Ischemia and Viability0
Contributors0
Framework for Digital Health Phenotypes in Heart Failure0
Spontaneous Coronary Artery Dissection0
Viability and Congestive Heart Failure0
Contents0
Cardiopulmonary Exercise Testing, Rehabilitation, and Exercise Training in Postpulmonary Embolism0
Utilizing Conversational Artificial Intelligence, Voice, and Phonocardiography Analytics in Heart Failure Care0
Baroreflex Activation Therapy in Patients with Heart Failure with a Reduced Ejection Fraction0
The War Against Heart Failure Hospitalizations0
The Ability of Near-Infrared Spectroscopy to Identify Vulnerable Patients and Plaques: A Systematic Review and Meta-Analysis0
SGLT2 Inhibitors Are Lifesavers in Heart Failure0
The Emerging Role of Artificial Intelligence in Valvular Heart Disease0
Amyloidosis and Amyloidogenesis0
Covid-190
Impact of Hormonal-Anabolic Deficiencies in Idiopathic Pulmonary Arterial Hypertension0
Forthcoming Issues0
Targeted Therapies for Microvascular Disease0
Renoprotective Effects of SGLT2 Inhibitors0
Cardiovascular Involvement in Transthyretin Cardiac Amyloidosis0
Forthcoming Issues0
Stress Testing in Heart Failure with Preserved Ejection Fraction0
Copyright0
Contributors0
0.12472701072693